Jaren Jackson Jr. Undergoes Successful Surgery for Knee Growth, Future with Jazz Uncertain

Utah Jazz center Jaren Jackson Jr. Underwent successful surgery on Tuesday, February 11, 2026, to remove a localized pigmented villonodular synovitis (PVNS) growth in his left knee, the team announced. Although the surgery was successful, his availability for the remainder of the 2025-26 NBA season remains uncertain.

What is PVNS?

Pigmented villonodular synovitis (PVNS) is a condition where the synovium – the tissue lining the joints – thickens and overgrows. According to the American Academy of Orthopedic Surgeons, this overgrowth is not cancerous and doesn’t spread, but it is a progressive disease that can lead to bone damage and arthritis. Surgery is typically required to remove the affected tissue.

Jackson’s Acquisition and Early Performance

The Jazz acquired Jackson from the Memphis Grizzlies on February 3, 2026, in a multi-player trade involving three first-round draft picks. He had shown promising early signs with his new team, averaging 22.3 points, 4.3 rebounds, and 2.0 steals in three games.

Recovery and Timeline

Jackson will begin post-surgery rehabilitation and will be re-evaluated in four weeks. While the team hasn’t ruled out a return this season, it is considered more likely that he will focus on preparing for the 2026-27 season.

Jackson’s Career Highlights

Prior to joining the Jazz, Jackson established himself as a key player for the Grizzlies. He was a two-time All-Star (2022-23, 2024-25) and earned the NBA Defensive Player of the Year award in 2022-23. He is a three-time All-Defensive selection and a two-time league leader in blocks.

Financial Implications

Jackson is currently in the second year of a contract that pays him $35 million this season, increasing to $50 million next season and over $52 million the following year.

Jazz’s Current Standing

As of February 18, 2026, the Utah Jazz hold a record of 18-38, placing them 13th in the Western Conference. The Memphis Grizzlies are 20-33 and in 11th place in the same conference.